In addition, loss-of-function mutations of the gene CPE (4q32.3) can inhibit the cleavage of POMC into melanocortins, resulting in a triad composed of severe obesity, developmental delay, and hypogonadotropic hypogonadism [59,74]. The gene discussed is POMC; the disease is obesity due to melanocortin 4 receptor deficiency.